FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

1425001000168104: cannabidiol 20 mg / 1 mL + delta-9-tetrahydrocannabinol 5 mg / 1 mL oral liquid, 40 mL (medicinal product pack)

Status: current, Defined. Date: 31-Dec 2019. Module: Australian Medicines Terminology module

Descriptions:

Id Description Lang Type Status Case? Module
4286321000168119 cannabidiol 20 mg / 1 mL + delta-9-tetrahydrocannabinol 5 mg / 1 mL oral liquid, 40 mL (medicinal product pack) en Fully specified name Active Case sensitive Australian Medicines Terminology module
4286331000168116 delta-9-tetrahydrocannabinol 5 mg/mL + cannabidiol 20 mg/mL oral liquid, 40 mL en Synonym Active Case sensitive Australian Medicines Terminology module

2 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
delta-9-tetrahydrocannabinol 5 mg/mL + cannabidiol 20 mg/mL oral liquid, 40 mL Is a medicinal product pack true Inferred relationship Some
delta-9-tetrahydrocannabinol 5 mg/mL + cannabidiol 20 mg/mL oral liquid, 40 mL has MPUU delta-9-tetrahydrocannabinol 5 mg/mL + cannabidiol 20 mg/mL oral liquid true Inferred relationship Some 362132721
Inbound Relationships Type Active Source Characteristic Refinability Group
Tilray FS THC 5:CBD 20 oral liquid, 40 mL Is a True delta-9-tetrahydrocannabinol 5 mg/mL + cannabidiol 20 mg/mL oral liquid, 40 mL Inferred relationship Some

Reference Sets

Schedule 8 medications reference set

Medicinal product pack reference set

Back to Start